Navigation Links
Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
Date:1/8/2008

cancer and study participants will be randomized in one of two arms of the trial (1:1), to receive either NKTR-102 and cetuximab or standard irinotecan and cetuximab. The Phase 2b stage is expected to begin in mid-year 2008 and will be conducted in over 40 centers worldwide. The primary endpoint of the Phase 2b trial is progression-free survival. Secondary endpoints include response rate, response duration, overall survival, standard pharmacokinetics, and incidence of toxicities, including diarrhea and neutropenia.

Prior Data Presentations for NKTR-102

Peer-reviewed presentations of preclinical study results for NKTR-102 were presented at ECCO 14 and the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in the fall of 2007. These presentations can be found at: http://www.nektar.com/wt/page/nktr102media

About NKTR-102

Nektar is developing NKTR-102, a PEGylated form of irinotecan, which was invented by Nektar using its world-leading small molecule PEGylation technology platform. The product is currently in Phase 2 clinical development. Irinotecan, also known as Camptosar, is an important chemotherapeutic agent used for the treatment of solid tumors, including colorectal and lung cancers. By applying Nektar's small molecule PEGylation technology to irinotecan, NKTR-102 may prove to be a more powerful and tolerable anti-tumor agent.

Preclinical studies show that treatment with NKTR-102 results in significant suppression of tumor growth in an irinotecan-resistant mouse colorectal tumor model. Administration of NKTR-102 in an animal model results in a significantly improved time-concentration profile for the active metabolite of irinotecan as compared to treatment with standard irinotecan.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its indu
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
2. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
3. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
4. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
5. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
6. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
7. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  Based on its ... market, Frost & Sullivan recognizes Siemens Healthcare with ... Siemens Healthcare,s FREEZEit solution, which employs Siemens, MAGNETOM ... robust and motion-insensitive imaging. The solution,s sophistication and ... of body MRI imaging in the U.S. market. ...
(Date:7/22/2014)... MANCHESTER, England , July 22, 2014 ... AEX:PHIA) announced today that The Christie NHS Foundation Trust ... center, will join a consortium whose mission is to ... imaging (MRI) guided radiation therapy system. Such a system ... real-time visualization of cancer targets. "The ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... HARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced,that, ... on the NYSE Amex,Market under the ticker symbol "CBP". , ... On this occasion, ...
... , SOMERVILLE, N.J. , July 7 ... surgical care, announced today the introduction of ETHICON™ ... designed to achieve adjunctive hemostasis (stoppage of bleeding) ... leakage. The US Food and Drug Administration (FDA) ...
Cached Medicine Technology:Renhuang Begins Trading on NYSE Amex 2Renhuang Begins Trading on NYSE Amex 3Renhuang Begins Trading on NYSE Amex 4Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 2Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 3
(Date:7/22/2014)... 22, 2014 Expert Publishing ... Services , announces the launch of PoisonEXPERT™ ... and safety professionals employed by organizations that use ... to manage the impact of chemicals on their ... to relevant chemical-specific information and medical protocols that ...
(Date:7/22/2014)... July 22, 2014 CyraCom has been ... (LSP) in the translation and interpreting industry. Released June ... the report titled "The Language Services Market: 2014," also ... the world, moving up two spots from 2013. , ... the LSPs that provide interpretation services – a subset ...
(Date:7/22/2014)... There’s an old adage that says first impressions ... and enhancements Global Eyeglasses has made, people across the ... while having what they need to sport the hottest ... are offering new sports clip prescription sunglasses and mirror ... of Global Eyeglasses . , Global Eyeglasses, ...
(Date:7/22/2014)... Austin, TX (PRWEB) July 22, 2014 ... been nominated for the 2014 Association for Healthcare Documentation ... instructor, Audrey Kirchner, who is the sole nominee for ... the Year awards. Her student, Linda Curia, is also ... worked in the medical transcription field for over 18 ...
(Date:7/22/2014)... The Muscular Dystrophy Association (MDA) and Jiffy Lube today ... campaign that will raise funds to help save and ... muscle disease. , As part of the campaign, ... centers through Sept. 1, 2014 to make a donation to ... the fight for muscle health. Since 2012, Jiffy Lube has ...
Breaking Medicine News(10 mins):Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Global Eyeglasses Adds New Products and Enhances Services 2Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 2Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 3Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3
... ... tissue and muscle pain therapy called the Active Release Technique. Active Release Technique is ... ... downtown NYC office, noted local chiropractor, Dr. Steven Shoshany, has recently expanded his ...
... A team of American psychologists and neuroscientists have found ... Anorexia Nervosa, can be regained. The research, published in ... that through specialist treatment patients with this eating disorder ... Anorexia Nervosa (AN) is a serious psychiatric ...
... ... MBA HealthGroup partner to increase physician adoption of electronic health records statewide , ... (PRWEB) May 26, 2010 ... Vermont, announced today that Vermont Information Technology Leaders, Inc. (VITL), the non-profit ...
... ... of Medical Services That Wastes Over 20 Cents of Every Dollar Spent , ... Lexington, MA (PRWEB) May 26, 2010 -- ... which are pivotal to the national healthcare debate, in the May issue of the ...
... ... DSPanel today announced the availability of their latest ... DSPanel announced the availability of DSPanel Performance Canvas 2.2 with Planning, ... designed to be used as an accompaniment to Sharepoint 2010 and ...
... ... to prescription sunglasses , ... New Jersey (PRWEB) May 26, 2010 -- With summer quickly approaching, GlassesUSA.com getting ... prescription glasses has been selling prescription sunglasses since the store opened. ...
Cached Medicine News:Health News:NYC Chiropractor Expands Practice with Therapy for Muscle and Overuse Injuries 2Health News:Brain volume found to change following weight gain in adults with anorexia 2Health News:MBA HealthGroup Selected as Preferred Partner by VITL 2Health News:HealthMETRICS Partners, Inc. Article in AJMC Outlines Innovative Approach to Combat Rising Healthcare Costs 2Health News:DSPanel's New Mobile Analytics Server for Business Intelligence: Data Analysis, Monitoring and Planning When and Where You Need It 2Health News:DSPanel's New Mobile Analytics Server for Business Intelligence: Data Analysis, Monitoring and Planning When and Where You Need It 3Health News:GlassesUSA.com Launches Section for Prescription Sunglasses 2
Take Performance to a Higher Level....
Rapid Exchange Stent Delivery System...
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
... The EVS has an ergonomic ... activated mechanism which requires a ... gently locks onto the target ... the site before, during and ...
Medicine Products: